Literature DB >> 17440703

A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.

Min Ae Lee-Kirsch1, Dipanjan Chowdhury, Scott Harvey, Maoliang Gong, Lydia Senenko, Kerstin Engel, Christiane Pfeiffer, Thomas Hollis, Manfred Gahr, Fred W Perrino, Judy Lieberman, Norbert Hubner.   

Abstract

We recently described a novel autosomal-dominant genodermatosis, termed familial chilblain lupus, and mapped its genetic locus to chromosome 3p21. Familial chilblain lupus manifests in early childhood with ulcerating acral skin lesions and is associated with arthralgias and circulating antinuclear antibodies. In this study, we report the identification of a heterozygous missense mutation (D18N) in TREX1 encoding the 3'-5'repair exonuclease 1 in affected individuals of the family with chilblain lupus. The homodimeric TREX1 is the most abundant intracellular DNase in mammalian cells. We have recently shown that TREX1 plays a role in apoptotic single-stranded DNA damage induced by the killer lymphocyte protease granzyme A. D18N affects a highly conserved amino acid residue critical for catalytic activity. Recombinant mutant TREX1 homodimers are enzymatically inactive, while wild type/mutant heterodimers show residual exonucleolytic activity, suggesting a heterozygous loss of function. Lymphoblastoid cells carrying the D18N mutation are significantly less sensitive to granzyme A-mediated cell death, suggesting a novel role for this caspase-independent form of apoptosis in the pathogenesis of familial chilblain lupus. Our findings also warrant further investigation of TREX1 in common forms of lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440703     DOI: 10.1007/s00109-007-0199-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  26 in total

1.  Systemic lupus erythematosus or Aicardi-Goutières syndrome?

Authors:  J Aicardi; F Goutières
Journal:  Neuropediatrics       Date:  2000-06       Impact factor: 1.947

2.  Excision of 3' termini by the Trex1 and TREX2 3'-->5' exonucleases. Characterization of the recombinant proteins.

Authors:  D J Mazur; F W Perrino
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

Review 3.  Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.

Authors:  Frédéric Rieux-Laucat
Journal:  Curr Dir Autoimmun       Date:  2006

4.  The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death.

Authors:  Dipanjan Chowdhury; Paul J Beresford; Pengcheng Zhu; Dong Zhang; Jung-Suk Sung; Bruce Demple; Fred W Perrino; Judy Lieberman
Journal:  Mol Cell       Date:  2006-07-07       Impact factor: 17.970

Review 5.  The lexicon of cutaneous lupus erythematosus--a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus.

Authors:  R D Sontheimer
Journal:  Lupus       Date:  1997       Impact factor: 2.911

6.  Mutation of DNASE1 in people with systemic lupus erythematosus.

Authors:  K Yasutomo; T Horiuchi; S Kagami; H Tsukamoto; C Hashimura; M Urushihara; Y Kuroda
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

7.  Encephalitis among Cree children in northern Quebec.

Authors:  D N Black; G V Watters; E Andermann; C Dumont; M E Kabay; P Kaplan; K Meagher-Villemure; J Michaud; G O'Gorman; E Reece
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

8.  Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.

Authors:  F Franceschini; P Calzavara-Pinton; M Quinzanini; I Cavazzana; L Bettoni; C Zane; F Facchetti; P Airò; D P McCauliffe; R Cattaneo
Journal:  Lupus       Date:  1999       Impact factor: 2.911

9.  Familial systemic lupus erythematosus and congenital infection-like syndrome.

Authors:  R C Dale; S P Tang; J Z Heckmatt; F M Tatnall
Journal:  Neuropediatrics       Date:  2000-06       Impact factor: 1.947

10.  A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.

Authors:  J Aicardi; F Goutières
Journal:  Ann Neurol       Date:  1984-01       Impact factor: 10.422

View more
  89 in total

1.  The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.

Authors:  Clinton D Orebaugh; Jason M Fye; Scott Harvey; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.

Authors:  Suzanna L Bailey; Scott Harvey; Fred W Perrino; Thomas Hollis
Journal:  DNA Repair (Amst)       Date:  2011-11-08

3.  B cell tolerance and positive selection in lupus.

Authors:  Dan Eilat; Matthias Wabl
Journal:  J Immunol       Date:  2012-07-15       Impact factor: 5.422

Review 4.  [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].

Authors:  C Günther; F Schmidt; N König; M A Lee-Kirsch
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 5.  Connections between antiviral defense and autoimmunity.

Authors:  Daniel B Stetson
Journal:  Curr Opin Immunol       Date:  2009-06-03       Impact factor: 7.486

6.  A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus.

Authors:  Kazuo Yamashiro; Ryota Tanaka; Yuanzhe Li; Michitaka Mikasa; Nobutaka Hattori
Journal:  J Neurol       Date:  2013-08-30       Impact factor: 4.849

7.  Deregulated type I IFN response in TREX1-associated familial chilblain lupus.

Authors:  Katrin Peschke; Franziska Friebe; Nick Zimmermann; Tom Wahlicht; Tina Schumann; Martin Achleitner; Nicole Berndt; Hella Luksch; Rayk Behrendt; Min Ae Lee-Kirsch; Axel Roers; Claudia Günther
Journal:  J Invest Dermatol       Date:  2013-11-22       Impact factor: 8.551

8.  The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.

Authors:  Duane A Lehtinen; Scott Harvey; Matthew J Mulcahy; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

Review 9.  Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Christian M Hedrich; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-08-30       Impact factor: 11.951

10.  Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.

Authors:  Jessica L Grieves; Jason M Fye; Scott Harvey; Jason M Grayson; Thomas Hollis; Fred W Perrino
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.